C2i Genomics
AcquiredCancer intelligence through AI and whole-genome sequencing
New York, United States · Founded 2019 · $112.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- c2i-genomics.com
- Total Funding
- $112.0M
- Last Round
- $100.0M Series BApr 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
C2i Genomics developed a cloud-based cancer intelligence platform that applies artificial intelligence and whole-genome sequencing to liquid biopsy samples to detect minimal residual disease (MRD) in cancer patients. The company's C2-Intelligence Platform analyzes blood samples to provide highly precise cancer detection and treatment monitoring, enabling pharmaceutical and diagnostic organizations to track cancer recurrence and optimize treatment decisions. C2i partnered with AstraZeneca and Premier Inc. before being acquired by Veracyte in February 2024.
Summary
C2i Genomics is an Artificial Intelligence company based in New York, United States, founded in 2019. It has raised $112.0M in total across 2 rounds, most recently a $100.0M Series B round in Apr 2021. Investors include Casdin Capital, NFX and The Mark Foundation for Cancer Research.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2021
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/c2i-genomics"><img src="https://indexed.vc/api/badge/company/c2i-genomics" alt="C2i Genomics on Indexed.vc" width="260" height="76" /></a>